Jefferies has put a buy recommendation on IndusInd Bank with the target price at Rs 920. Analysts said the bank has appointed Rajiv Anand as next MD & CEO for three years. Given his long standing stint at Axis Bank, where he was a deputy managing director, analysts see this as a key positive for the lender. A reorganization of the top management of the team may be the key initial steps for Anand, analysts said. They would also watch out for joiners from Axis and other banks. The key expectations would be improved fee, assets and operating efficiency, besides restoration of the bank’s credibility, they said.Nuvama has downgraded ABB India to hold from buy with the target price cut to Rs 5,400 from Rs 6,650 earlier. Analysts said the company reported weak large-ticket order inflows amid cyclical slowdown and margin pressure is expected to continue. They have cut the company’s earnings per share (EPS) by 11% for CY25 and by 9% for CY26. Also price-to-earnings (P/E) ratio has been revised to 55x from 65x. Analysts said profit after tax (PAT) margin guidance of 12-15% depends on quarterly order inflow of Rs 3,800 crore to Rs 4,000 crore. Private capex revival and order pipeline key to upside, they said.Macquarie maintained an outperform rating on AB Capital with the target price at Rs 335. Analysts said the company was on a strong footing with the NBFC reporting PAT that was in line with estimates, while its operating leverage drove return on assets (ROA) expansion. The company’s credit costs were stable but stress increased in the unsecured SME space.UBS has a buy rating on MCX with the target price at Rs 10,000. Analysts said there were three main takeaways from the company’s recent concall. For one, MCX wants to focus on launching new products, including cash-settled index options; increase retail participation, particularly in bullion, and it’s making efforts to enhance liquidity in electricity derivatives. The company’s board recently approved a stock split (1:5 ratio).Goldman Sachs maintained buy rating on Marico with the target price hiked to Rs 800 from Rs 780. Analysts said that the company reported a strong broad based volume growth acceleration to 9%, which was highest among the FMCG peers. The company’s turnaround in its value-added hair oil business was a key positive, and new businesses surpassed growth metric expectations. The company has set aggressive targets for FY28 growth and profitability. However, unprecedented inflation in copra has pushed out margin recovery to FY27.(Disclaimer: The opinions, analyses and recommendations expressed herein are those of brokerage and do not reflect the views of The Times of India. Always consult with a qualified investment advisor or financial planner before making any investment decisions.)
